Thermo Fisher plans sale of 15,000 shares

Thermo Fisher Scientific’s affiliate filed to permit the public resale of 15,000 shares of common stock on the NYSE, with an aggregate market value of $8,652,000.00 and 369,747,286 common shares outstanding as of August 6, 2026.

Rhea-AI Filing Summary

Thermo Fisher Scientific’s affiliate filed to permit the public resale of 15,000 shares of common stock on the NYSE, with an aggregate market value of $8,652,000.00 and 369,747,286 common shares outstanding as of August 6, 2026.

The shares derive from a planned 10,000-share stock option exercise on August 6, 2026 and 5,000 shares from restricted stock vesting events in 2013 and 2015. Over the prior three months, Floral Park Associates Inc. sold 5,000 shares for $2,876,145.43 and Marc N. Casper sold 10,000 shares for $5,752,296.00.

Key Figures

Shares to be sold: 15,000 shares Aggregate market value: $8,652,000.00 Shares outstanding: 369,747,286 shares +4 more

7 metrics

Shares to be sold 15,000 shares Common stock planned for resale on NYSE

Aggregate market value $8,652,000.00 Value of 15,000 shares referenced in the filing

Shares outstanding 369,747,286 shares Common shares outstanding as of August 6, 2026

Stock option exercise shares 10,000 shares Planned stock option exercise on August 6, 2026

Restricted stock vesting total 5,000 shares 1,500 vested on February 15, 2013 and 3,500 on February 26, 2015

Floral Park Associates sale 5,000 shares for $2,876,145.43 Common stock sale on August 5, 2026

Marc N. Casper sale 10,000 shares for $5,752,296.00 Common stock sale on August 5, 2026

Key Terms

Form 144, Stock Option Exercise, Restricted Stock Vesting

3 terms

Form 144 regulatory

"144: Securities Information Common | Fidelity Brokerage Services LLC"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option Exercise financial

"Common | 08/06/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Restricted Stock Vesting financial

"Common | 02/15/2013 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Thermo Fisher (TMO) plan to sell under this Form 144 filing?

The filing covers a planned resale of 15,000 shares of Thermo Fisher common stock on the NYSE, with an aggregate market value of $8,652,000.00 as referenced in the disclosure.

How many Thermo Fisher (TMO) shares are outstanding in this Form 144?

The document states that 369,747,286 Thermo Fisher common shares were outstanding as of August 6, 2026, providing context for the relative size of the 15,000-share planned sale.

What is the source of the Thermo Fisher (TMO) shares to be sold?

The 15,000 shares come from a planned 10,000-share stock option exercise on August 6, 2026 and 5,000 shares from restricted stock vesting events in 2013 and 2015.

What Thermo Fisher (TMO) share sales occurred in the past three months?

In the prior three months, Floral Park Associates Inc. sold 5,000 shares for $2,876,145.43, and Marc N. Casper sold 10,000 shares for $5,752,296.00, both in Thermo Fisher common stock.

Who is named in the recent Thermo Fisher (TMO) Form 144 sales history?

The past three-month sales history lists Floral Park Associates Inc. and Marc N. Casper as sellers of Thermo Fisher common stock, with specified share amounts and total sale values.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/06/2026 - 02:44 PM Accepted by SEC EDGAR 08/06/2026 - 02:43 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001216055
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	THERMO FISHER SCIENTIFIC INC.
SEC File Number	001-08002
Address of Issuer	168 THIRD AVENUE WALTHAM MASSACHUSETTS 02451
Phone	7816221000
Name of Person for Whose Account the Securities are To Be Sold	CASPER MARC N
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	15000	8652000.00	369747286	08/06/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/06/2026	Stock Option Exercise	Issuer			10000	08/06/2026	Cash
Common	02/15/2013	Restricted Stock Vesting	Issuer			1500	02/15/2013	Compensation
Common	02/26/2015	Restricted Stock Vesting	Issuer			3500	02/26/2015	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Floral Park Associates Inc 168 Third Avenue Waltham MA 02451	Common	08/05/2026	5000	2876145.43
Marc N. Casper 168 Third Avenue Waltham MA 02451	Common	08/05/2026	10000	5752296.00

144: Remarks and Signature

Remarks	Of today's sales, 5,000 shares were sold from the Floral Park Associates Inc. account of which Marc N. Casper is an authorized individual and account stakeholder
Date of Notice	08/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	04/27/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Marc N. Casper
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)